Changes in therapy and survival of metastatic renal cell carcinoma in Estonia

Abstract Background Before the era of targeted therapies, cytokines were the main therapy for metastatic renal cell carcinoma (mRCC). Our aim was to analyze the changes in treatments and overall survival (OS) of all mRCC patients in Estonia in relation to the introduction of new medications. Methods...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hannes Jürgens, Kristiina Ojamaa, Helis Pokker, Kaire Innos, Peeter Padrik
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-03-01
Colecção:BMC Cancer
Assuntos:
Metastatic renal cell carcinoma
National cohort
Overall survival
Targeted therapy
Acesso em linha:http://link.springer.com/article/10.1186/s12885-020-6685-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados